Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06444295 · ClinicalTrials.gov registry record · NA
Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault
A NA study of Alcohol Drinking and Alcohol Problem, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 464
- Enrollment target
- 1
- Study location
NCT06444295: Recruiting NA study of Alcohol Drinking and Alcohol Problem, sponsored by University of Washington.
NCT06444295 is a NA study of Alcohol Drinking and Alcohol Problem that is actively recruiting participants, run by University of Washington. The registered enrollment target is 464 participants, below the 625-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06444295, a NA study of Alcohol Drinking and Alcohol Problem, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 464 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to find the most effective and efficient version of the THRIVE app. The THRIVE app is the first app-based preventative intervention that has been found to reduce alcohol misuse and posttraumatic stress in people who have recently experienced sexual assault. In this trial, participants are randomly assigned to receive different versions of the THRIVE app to compare their impact. The THRIVE app is currently only available to participants in this study.
Primary Outcome
Assessed using the 16-item Short Form Rutgers Alcohol Problem Index (S-RAPI). Minimum score = 0, maximum score = 64, higher scores mean greater severity of problems.
Conditions Studied
Interventions
- BEHAVIORAL Activity scheduling
- BEHAVIORAL Cognitive restructuring
- BEHAVIORAL Coaching calls
- BEHAVIORAL Non-core intervention components
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 464 participants |
| Start Date | 2024-07-29 |
| Est. Completion | 2027-07-15 |
| Phase | NA |
What NCT06444295 shows while recruiting
NCT06444295 is an interventional study that assigns participants to a tested intervention. The registered 464 participants enrollment target is mid-sized for trials with a published cap, below the 625-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (26% lower).
The record links to 3 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 4 interventions - of which Activity scheduling is the first listed.
NCT06444295 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06444295 about?
NCT06444295 is a clinical study titled "Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault". The goal of this study is to find the most effective and efficient version of the THRIVE app. The THRIVE app is the first app-based preventative intervention that has been found to reduce alcohol misuse and posttraumatic stress in people who have recently experienced sexual assault. In this trial, p...
What is the current status of trial NCT06444295?
This trial is currently recruiting. It is a NA study. The enrollment target is 464 participants. The study started on 2024-07-29. Estimated completion is 2027-07-15.
What conditions does trial NCT06444295 study?
This clinical trial studies the following conditions: Alcohol Drinking, Alcohol Problem, Posttraumatic Stress Symptom.
What interventions are being tested in trial NCT06444295?
The interventions under investigation include: Activity scheduling (BEHAVIORAL), Cognitive restructuring (BEHAVIORAL), Coaching calls (BEHAVIORAL), Non-core intervention components (BEHAVIORAL).
Who is sponsoring clinical trial NCT06444295?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06444295 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06444295's enrollment target sits among peer trials
464 22nd of 85 higher than 64 of 85 other Alcohol Drinking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
-
Multi-Component Breath Alcohol Intervention Phase 3
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- NCT04855656 · 464 participants · Phase 1
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
- NCT06283927 · 464 participants
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- NCT07403721 · 464 participants · Phase 1
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI